Table 1.

Incidence of reported side effects of anagrelide in 35 young patients with essential thrombocythemia during the first 3 months of treatment (initial) and afterward (long term)

HeadacheTachycardiaEdemaDiarrhea
Initial 34.2% 22.8% 14.2% 8.5% 
Long term 5.7% 8.5% 5.7% 0%  
HeadacheTachycardiaEdemaDiarrhea
Initial 34.2% 22.8% 14.2% 8.5% 
Long term 5.7% 8.5% 5.7% 0%  
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal